582
Participants
Start Date
November 2, 2012
Primary Completion Date
February 5, 2015
Study Completion Date
December 17, 2021
Nivolumab
Docetaxel
Local Institution - 0043, Hong Kong
Local Institution - 0131, Miraflores
Local Institution - 0048, Lima
Local Institution - 0050, Arequipa
Local Institution, Vienna
Local Institution - 0010, Capital Federal
Local Institution - 0057, Capital Federal
Local Institution, Tweed Heads
Local Institution, Melbourne
Local Institution, Frankston
Local Institution, Linz
Local Institution, Basel
Local Institution, Woolloongabba
Local Institution, Wels
Local Institution, Adelaide
Local Institution, Salzburg
Local Institution, Kurralta Park
Local Institution - 0125, La Rioja
Local Institution, Chur
Local Institution - 0020, New York
Local Institution - 0008, Mineola
Local Institution - 0112, Marseille
Local Institution - 0108, Mexico City
Local Institution - 0035, Sayre
St. Mary Medical Center, Langhorne
Fox Chase Cancer Center, Philadelphia
Local Institution - 0085, Milan
Local Institution, Dijon
The Johns Hopkins University, Baltimore
Local Institution, Großhansdorf
Local Institution - 0122, Bergamo
Local Institution - 0027, Durham
Local Institution, Madrid
Local Institution, Madrid
Local Institution - 0025, Columbia
Northwest Georgia Oncology Center, P.C., Marietta
Local Institution, Toulouse
Local Institution - 0034, Tampa
Local Institution - 0114, Rennes
Local Institution - 0084, Padua
Local Institution - 0028, Nashville
Vanderbilt University Medical Center, Nashville
Local Institution - 0024, Chattanooga
Local Institution - 0086, Bologna
Local Institution - 0001, Seville
Local Institution - 0121, Parma
Local Institution - 0026, Cincinnati
Local Institution, Recklinghausen
Local Institution - 0087, Meldola (fc)
Local Institution - 0088, Ravenna
Local Institution, Vizcaya
Local Institution - 0090, Cologne
Local Institution - 0082, Siena
Local Institution, Mainz
Local Institution - 0030, Chicago
Local Institution, Monterrey
Local Institution, Heidelberg
Local Institution - 0113, Lyon
Local Institution, Stuttgart
Local Institution - 0067, Szczecin
Local Institution - 0033, Dallas
Local Institution - 0032, Houston
Local Institution, Hermosillo
Mayo Clinic Arizona, Scottsdale
Local Institution - 0119, La Roche-sur-Yon
Local Institution, Poitiers
Local Institution, Ulm
Local Institution - 0009, Duarte
Local Institution - 0042, San Diego
Local Institution, Créteil
San Francisco Oncology Associates, San Francisco
Swedish Cancer Institute, Seattle
Local Institution - 0007, Seattle
Local Institution - 0041, Kennewick
Local Institution, Bad Berka
Local Institution, Singapore
Local Institution - 0080, Saint Petersburg
Local Institution - 0063, Craiova
Local Institution - 0062, Timișoara
Local Institution, Singapore
Local Institution - 0123, Cluj-Napoca
Local Institution - 0061, Iași
Local Institution - 0058, Santiago
Local Institution - 0077, Santiago
Local Institution - 0056, Fortaleza
Yale University, New Haven
Local Institution - 0031, Boston
Local Institution - 0040, Boston
Local Institution - 0138, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Local Institution - 0019, Morgantown
Local Institution - 0124, Ciudad de Buenos Aires
Local Institution - 0011, Buenos Aires
Local Institution - 0054, Salvador
Local Institution - 0053, Porto Alegre
Local Institution - 0055, Porto Alegre
Local Institution - 0052, Barretos
Local Institution - 0051, Rio de Janeiro
Local Institution - 0133, Edmonton
Local Institution, London
Local Institution - 0110, Rimouski
Local Institution - 0012, Viña del Mar
Local Institution - 0134, Santiago
Local Institution, Hong Kong
Local Institution - 0018, Prague
Local Institution - 0074, Budapest
Local Institution - 0083, Perugia
Local Institution - 0107, Mexico City
Local Institution - 0141, Oslo
Local Institution - 0049, Lima
Local Institution - 0073, Krakow
Local Institution - 0068, Gdansk
Local Institution - 0072, Olsztyn
Local Institution - 0070, Warsaw
Local Institution - 0099, Bucharest
Local Institution - 0078, Moscow
Local Institution - 0079, Moscow
Local Institution - 0120, Moscow
Local Institution, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY